Publications
Romer C, Johnson FL, ChowdhuryJ, Rosenblatt R, Kivanc A, Holloway M, Warren L, Crowe S, Hopwood B. Understanding Attitudes and Experiences Relating to Diabetes in the Kurdish, Turkish and Turkish-Cypriot Communities in North Central London, and Exploring Engagement Approaches as a Means of Improving Awareness and Self-management: a qualitative study. Diabet Med 2020; 37 (Suppl 1):90–118, P294.
Marshall DC, Holloway M, Korer M, Woodman J, Brackenridge A, Hussain S. Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: perspectives of two adult users, a caregiver and three physicians. Diabetes Ther 2019;10:1553–1564. https://doi.org/10.1007/s13300-019-00679-y
Parkin CG, Holloway M, Truesdell J, Walker T. Is Continuous Glucose Monitoring Underappreciated in the UK? European Endocrinology 2017;13(2):76–80. (http://www.touchendocrinology.com/articles/continuous-glucose-monitoring-underappreciated-uk)
Snell GL, Trevatt P, Thomas S, Holloway MP. Living With Diabetes in London: the patient experience. Diabet Med 2016; 33 (Suppl 1):5–196, P492.(http://onlinelibrary.wiley.com/doi/10.1111/dme.51_13048/epdf)
Pickup JC, Holloway M, Samsi K. Real-time Continuous Glucose Monitoring in Type 1 Diabetes: a qualitative framework analysis of patient narratives. Diabetes Care 2015;38(4):544–550.(http://care.diabetesjournals.org/content/38/4/544)
Continuous Glucose Monitoring Summit: white paper. American Association of Diabetes Educators, June 2015.
Insulin Pump Therapy: best practices in choosing and using infusion devices. American Association of Diabetes Educators, November 2011.
Insulin Pump Therapy: guidelines for successful outcomes. American Association of Diabetes Educators, March 2009.
Ford MP. A User Perspective on Continuous Subcutaneous Insulin Infusion (CSII) therapy. The British Journal of Diabetes & Vascular Disease 2004;4(2):110–111.(http://journals.sagepub.com/doi/abs/10.1177/14746514040040020801)
Ford M. It’s Not a Beeper, It’s My Insulin Pump, Medscape Diabetes & Endocrinology, July 2003.